Healthcare - Biotechnology - NASDAQ - US
$ 0.00045
0 %
$ 8.54 K
Market Cap
0.0
P/E
BALANCE SHEET
64.4 M
ASSETS
69.4 M
LIABILITIES
-4.99 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Evelo Biosciences, Inc.
| Current Assets | 51.6 M |
| Cash & Short-Term Investments | 47.9 M |
| Receivables | 0 |
| Other Current Assets | 3.63 M |
| Non-Current Assets | 12.9 M |
| Long-Term Investments | 0 |
| PP&E | 11.7 M |
| Other Non-Current Assets | 1.16 M |
| Current Liabilities | 12.4 M |
| Accounts Payable | 1.76 M |
| Short-Term Debt | 2.26 M |
| Other Current Liabilities | 8.37 M |
| Non-Current Liabilities | 57 M |
| Long-Term Debt | 5.26 M |
| Other Non-Current Liabilities | 51.8 M |
Balance Sheet
Millions
| Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Cash & Cash Equivalents | 47.9 | 68.4 | 68.9 | 77.8 | 147.9 | 38.2 | 15.5 |
| Short Term Investments | 0 | 0 | 0 | 0 | 54.8 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 3.6 | 2.6 | 2.1 | 3.2 | 3.7 | 0.5 | 0.2 |
| Total Current Assets | 51.6 | 71.0 | 68.9 | 77.8 | 147.9 | 38.8 | 15.7 |
| PP&E | 11.7 | 15.5 | 18.2 | 8.3 | 6.9 | 3.5 | 2.5 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 1.2 | 1.3 | 3.5 | 4.7 | 5.0 | 1.5 | 0.3 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 64.4 | 87.9 | 90.6 | 90.9 | 159.9 | 43.8 | 18.6 |
| LIABILITIES | |||||||
| Accounts Payable | 1.8 | 1.6 | 1.4 | 0.6 | 1.5 | 1.4 | 0.6 |
| Short Term Debt | 2.3 | 3.9 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 8.4 | (7.0) | 18.4 | 9.1 | 7.7 | 2.4 | 1.6 |
| Total Current Liabilities | 12.4 | 17.4 | 19.8 | 9.7 | 9.2 | 3.8 | 2.2 |
| Long Term Debt | 5.3 | 54.3 | 40.0 | 19.6 | 12.3 | 10.0 | 9.9 |
| Deferred Tax Income | 0 | (7.5) | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 51.8 | 0 | 0.3 | 1.3 | 1.4 | 0.6 | 0.9 |
| Total Liabilities | 69.4 | 79.2 | 60.2 | 30.7 | 22.9 | 14.4 | 13.0 |
| EQUITY | |||||||
| Common Stock | 0.1 | 54 K | 47 K | 32 K | 32 K | 20 K | 4 K |
| Retained Earnings | (529.2) | (414.7) | (292.5) | (198.9) | (113.4) | (56.4) | (28.3) |
| Other Accumulative Comprehensive Income/Loss | 0 | 0 | 0 | (90.9) | 18 K | (1.4) | (0.6) |
| Total Equity | (5.0) | 8.7 | 30.5 | 60.2 | 136.9 | 29.4 | 5.5 |
| Total Liabilities and Equity | 64.4 | 87.9 | 90.6 | 90.9 | 159.9 | 43.8 | 18.6 |
| SHARES OUTSTANDING | |||||||
| Common Shares Outstanding | 4.4 | 2.6 | 2.0 | 1.6 | 1.1 | 0.2 | 0.1 |